Top Markets
Coin of the day
CytoMed Therapeutics Limited CytoMed Therapeutics Limited

CytoMed Therapeutics Limited

GDTC
Rang in aandelen #32328
CytoMed Therapeutics Limited is a biopharmaceutical company in the pre-clinical... CytoMed Therapeutics Limited is a biopharmaceutical company in the pre-clinical development phase, founded in 2018 and based in Singapore. The firm specializes in creating advanced cellular immunotherapies aimed at combating various human malignancies. Its primary investigational product, CTM-N2D, involves cultivated gamma delta T cells that are engineered with a chimeric antigen receptor (CAR) specifically targeting natural killer group 2D ligands, designed to boost their capacity to destroy cancer cells. Beyond its lead candidate, CytoMed is also advancing iPSC-gdNKT, which utilizes induced pluripotent stem cells (iPSCs) to generate a novel hybrid cell combining properties of both gamma delta T cells and natural killer cells. Additionally, the company is developing CTM-GDT, an immunotherapy consisting of expanded gamma delta T cells that leverages their innate, broad-spectrum recognition system to identify and address diverse cancer types.
Aandeelprijs
$0.88
Laatst gesynchroniseerd: 2026-08-17
Marktkapitalisatie
$10.41M
Verandering (1 dag)
-7.26%
Verandering (1 jaar)
-50.56%
Land
SG
Handel CytoMed Therapeutics Limited (GDTC)

Categorie

Aandelsplitsingen voor CytoMed Therapeutics Limited (GDTC)
Het aandeel CytoMed Therapeutics Limited (symbool: GDTC) heeft in totaal 0 splitsingen ondergaan.
De meest recente splitsing vond plaats op Aug 18, 2026.
Eén aandeel GDTC dat vóór Aug 18, 2026 werd gekocht, staat nu gelijk aan 0 aandelen GDTC.
Lijst van aandelen splitsingen
Jaar Splitsing Vermenigvuldiging Cumulatieve vermenigvuldiging
Niet genoeg gegevens voor de verstrekte datums.
Aandelsplitsingen van vergelijkbare bedrijven of concurrenten
Bedrijf Aantal aandelen splitsingen Cumulatieve vermenigvuldiging Land
1 x2
US
0 -
NL
1 x3
AU
0 -
CH
0 -
KR